Arcturus Therapeutics Holdings Inc. (ARCT) has a market capitalization of $246.71M and trades at $8.68. The 52-week range is 5.85-24.17.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.6, Earnings Per Share (EPS) of $-2.40, annual revenue of $67.22M.
The stock has a beta of 2.44, operates in the Healthcare sector.